HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

14.900

-0.900-5.70%

Volume:561.40K

Turnover:8.48M

Market Cap:4.81B

PE:-9.38

High:15.800

Open:15.800

Low:14.900

Close:15.800

52wk High:206.000

52wk Low:14.900

Shares:323.00M

HK Float Shares:152.00M

Volume Ratio:0.98

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.588

ROE:-31.30%

ROA:-10.46%

PB:2.84

PE(LYR):-9.38

PS:241.81

Loading ...

Overview Company News Filings

BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10

Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity

Bulletin Express

Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share

BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval

BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback

Bulletin Express

BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8

Bao Pharma appoints new joint company secretary and secures Listing Rules waiver

Bulletin Express

BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary

Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent

Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600

Bulletin Express

BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6

Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares

Bulletin Express

Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65

Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection

BAO PHARMA-B Surges Over 10% In Session Following Clinical Trial Approval for Recombinant Ulinastatin

Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%

Bulletin Express

BAO PHARMA-B (02659) Repurchases 95,200 Shares for Approximately HK$1.686 Million on June 30

Shanghai Bao Pharma Files HKEX Next-day Disclosure on Share Buyback at HKD 17.38-17.81

Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection

Yidu Tech Achieves Historic Annual Profit Turnaround; Key HKEX Announcements on M&A, Clinical Trials, and AI Partnerships

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/02659/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":14.9,"timestamp":1789027722217,"preClose":15.8,"halted":0,"volume":561400,"delay":0,"changeRate":-0.056962025316455715,"floatShares":152000000,"shares":323000000,"eps":-1.5883943414572943,"marketStatus":"Not Yet Opened","change":-0.9,"latestTime":"09-10 16:08:42","open":15.8,"high":15.8,"low":14.9,"amount":8480940,"amplitude":0.056962,"askPrice":15.02,"askSize":1500,"bidPrice":14.9,"bidSize":19900,"shortable":0,"etf":0,"ttmEps":-1.3820432295097391,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":15.8,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.9786966982990407,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":152000000,"roa":"-10.46%","roe":"-31.30%","lyrEps":-1.588394,"volumeRatio":0.9786966982990407,"shares":323000000,"dividePrice":0,"high":15.8,"amplitude":0.056962,"preClose":15.8,"low":14.9,"week52Low":14.9,"pbRate":"2.84","psRate":"241.81","week52High":206,"institutionHeld":0,"latestPrice":14.9,"committee":0.859813,"eps":-1.5883943414572943,"divideRate":0,"volume":561400,"delay":0,"ttmEps":-1.3820432295097391,"open":15.8,"prevYearClose":77.55,"prevWeekClose":16.06,"prevMonthClose":16.44,"prevQuarterClose":18,"fiveDayClose":16.43,"twentyDayClose":17.07,"sixtyDayClose":18.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-26","symbol":"02659","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1779984000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-09-09","current":-10.780632,"percent":0.912088,"low":-150.791275,"twenty":-74.902076,"median":-49.027166,"eighty":-12.705803,"high":-11.128507,"avg":-45.865517,"sd":35.75087,"marketCap":5149002987},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-20","current":-138.174242,"twenty":-79.686668,"median":-71.167377,"eighty":-56.115318,"marketCap":59426421069},{"date":"2026-02-27","current":-116.132786,"twenty":-104.714701,"median":-73.426035,"eighty":-56.395698,"marketCap":50494528928},{"date":"2026-03-06","current":-76.640212,"twenty":-111.983375,"median":-74.892856,"eighty":-56.998352,"marketCap":33054520551},{"date":"2026-03-13","current":-75.987902,"twenty":-110.582832,"median":-75.36732,"eighty":-57.563278,"marketCap":32924127965},{"date":"2026-03-20","current":-70.725897,"twenty":-109.509649,"median":-74.892856,"eighty":-57.733099,"marketCap":30528164197},{"date":"2026-03-27","current":-65.400661,"twenty":-104.714701,"median":-74.674242,"eighty":-58.326024,"marketCap":29273135557},{"date":"2026-04-02","current":-74.510382,"twenty":-96.653813,"median":-73.605533,"eighty":-59.04256,"marketCap":33510894602},{"date":"2026-04-10","current":-71.602503,"twenty":-91.308972,"median":-74.057958,"eighty":-59.568794,"marketCap":32451454840},{"date":"2026-04-17","current":-64.454748,"twenty":-86.399914,"median":-73.087213,"eighty":-60.479603,"marketCap":29224238337},{"date":"2026-04-24","current":-55.967849,"twenty":-84.718643,"median":-71.1642,"eighty":-60.173931,"marketCap":25377657050},{"date":"2026-04-30","current":-18.543355,"twenty":-83.426575,"median":-70.300184,"eighty":-58.506399,"marketCap":8410321797},{"date":"2026-05-08","current":-19.625214,"twenty":-81.092081,"median":-69.74185,"eighty":-56.760202,"marketCap":8931892141},{"date":"2026-05-15","current":-17.930681,"twenty":-79.944236,"median":-68.961959,"eighty":-55.831299,"marketCap":8182134771},{"date":"2026-05-22","current":-17.55647,"twenty":-79.579829,"median":-66.237091,"eighty":-53.674239,"marketCap":7993065521},{"date":"2026-05-29","current":-17.509903,"twenty":-78.962132,"median":-66.085797,"eighty":-51.516739,"marketCap":7999585151},{"date":"2026-06-05","current":-15.389804,"twenty":-78.220574,"median":-65.202887,"eighty":-19.743808,"marketCap":7041199644},{"date":"2026-06-12","current":-13.774642,"twenty":-77.936107,"median":-64.592987,"eighty":-19.178821,"marketCap":6297961903},{"date":"2026-06-18","current":-12.785133,"twenty":-77.726882,"median":-64.454748,"eighty":-18.7468,"marketCap":5857886926},{"date":"2026-06-26","current":-11.736313,"twenty":-77.358698,"median":-62.675612,"eighty":-18.25553,"marketCap":5352615655},{"date":"2026-07-03","current":-13.348826,"twenty":-77.285436,"median":-61.290684,"eighty":-17.828553,"marketCap":6092593580},{"date":"2026-07-10","current":-14.187594,"twenty":-77.122448,"median":-60.663453,"eighty":-17.509903,"marketCap":6467472265},{"date":"2026-07-17","current":-12.348746,"twenty":-76.777398,"median":-59.36056,"eighty":-15.389804,"marketCap":5649258788},{"date":"2026-07-24","current":-12.28898,"twenty":-76.640212,"median":-57.965274,"eighty":-14.102609,"marketCap":5623180271},{"date":"2026-07-31","current":-12.265678,"twenty":-76.228711,"median":-57.553252,"eighty":-13.925373,"marketCap":5623180271},{"date":"2026-08-07","current":-12.759971,"twenty":-76.015489,"median":-56.434485,"eighty":-13.758151,"marketCap":5861146740},{"date":"2026-08-14","current":-11.978357,"twenty":-75.491436,"median":-55.967849,"eighty":-13.50755,"marketCap":5509086758},{"date":"2026-08-21","current":-11.379099,"twenty":-75.31975,"median":-54.455852,"eighty":-13.139203,"marketCap":5245041771},{"date":"2026-08-28","current":-11.185615,"twenty":-75.047246,"median":-53.651638,"eighty":-12.841314,"marketCap":5157026776},{"date":"2026-09-04","current":-12.259564,"twenty":-74.97059,"median":-51.596245,"eighty":-12.752538,"marketCap":5233733415},{"date":"2026-09-09","current":-12.041818,"twenty":-74.902076,"median":-49.027166,"eighty":-12.705803,"marketCap":5149002987}],"updateTime":1789078530824},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166944628","title":"BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1166944628","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166944628?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:07","pubTimestamp":1783678070,"startTime":"0","endTime":"0","summary":"The company announced that on July 10, 2026, it repurchased 149,800 shares at a total cost of HK$2.9929 million.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111716596","title":"Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=1111716596","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111716596?lang=en_us&edition=fundamental","pubTime":"2026-07-09 19:06","pubTimestamp":1783595182,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a repurchase of 153,200 H-shares on 9 July 2026, executed on the Hong Kong Stock Exchange. The transaction was completed at prices...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650925679","title":"Shanghai Bao Pharma Files HKEX Return Disclosing Share Buyback at HKD 19.53 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2650925679","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650925679?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:38","pubTimestamp":1783593502,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX return disclosing share buyback at HKD 19.53 per shareShanghai Bao Pharmaceuticals repurchased 153,200 H shares on July 9, 2026 for treasury, with no shares bought for c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL82tvdg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156096333","title":"BAO PHARMA-B Surges Over 6% in Session as World's First Synthetic Biology Recombinant Ulinastatin BJ044 Gains Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1156096333","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156096333?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563677,"startTime":"0","endTime":"0","summary":"Shares of BAO PHARMA-B (02659) surged more than 6% in early trading. At the time of writing, the stock is up 2.76%, trading at HK$20.10 with a turnover of HK$7.1887 million. In late June, the company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160306991","title":"BAO PHARMA-B Cuts Free Float by 0.09% Through HKD 2.84 Million Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1160306991","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160306991?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:03","pubTimestamp":1783508600,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (BAO PHARMA-B) reported a share repurchase on 8 July 2026, cancelling 0.09% of its outstanding H-share free float in a single trading session. • Transaction...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114896920","title":"BAO PHARMA-B Repurchases Shares Worth HK$2.84 Million on July 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1114896920","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114896920?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:50","pubTimestamp":1783507837,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has disclosed details of a recent share buyback transaction.The company announced that on July 8, 2026, it executed a repurchase of 145,600 of its own shares.The total...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131855067","title":"Bao Pharma appoints new joint company secretary and secures Listing Rules waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=1131855067","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131855067?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:03","pubTimestamp":1783504997,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) announced that Ms. Fong Christine Haiman will step down as joint company secretary, authorised representative and process agent with effect from 8...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168820240","title":"BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1168820240","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168820240?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:55","pubTimestamp":1783504559,"startTime":"0","endTime":"0","summary":"BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649962199","title":"Shanghai Bao Pharma Appoints Tsang Chun Ho as Joint Company Secretary, Authorized Representative and Process Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2649962199","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649962199?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:50","pubTimestamp":1783504205,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma appoints Tsang Chun Ho as joint company secretary, authorized representative and process agentShanghai Bao Pharmaceuticals appointed Tsang Chun Ho as joint company secretary, autho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL1kRccX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122343240","title":"Bao Pharma repurchases 137,300 H-shares, treasury stock climbs to 284,600","url":"https://stock-news.laohu8.com/highlight/detail?id=1122343240","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122343240?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:04","pubTimestamp":1783422249,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a next-day return showing an on-market repurchase of 137,300 H-shares on 7 July 2026. • Transaction details: Shares were bought back on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183461123","title":"BAO PHARMA-B Repurchases 52,100 Shares for Approximately HK$971,400 on July 6","url":"https://stock-news.laohu8.com/highlight/detail?id=1183461123","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183461123?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:11","pubTimestamp":1783336260,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (ASX: 02659) announced that on July 6, 2026, the company executed a share repurchase. The transaction involved approximately 52,100 shares at a total cost of about HK$971,400. The repurchase price per share ranged from HK$18.19 to HK$18.68.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113048495","title":"Bao Pharma Buys Back 52,100 H-Shares, Treasury Stock Rises to 147,300 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1113048495","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113048495?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:07","pubTimestamp":1783336024,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (“Bao Pharma”) reported a share buyback on 6 July 2026, purchasing 52,100 H-shares on the Hong Kong Stock Exchange for an aggregate HK$0.97 million. The shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649255276","title":"Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure After Share Buyback at HKD 18.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2649255276","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649255276?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:58","pubTimestamp":1783335534,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals files HKEX next-day disclosure after share buyback at HKD 18.65Shanghai Bao Pharmaceuticals repurchased 52,100 H shares on July 6, 2026 for treasury; no shares were repurc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL89P23T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649964964","title":"Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2649964964","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649964964?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:15","pubTimestamp":1783322126,"startTime":"0","endTime":"0","summary":"June 30 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd <2659.HK>::*NMPA APPROVES IND APPLICATION FOR BJ044 INJECTION, PERMITTING CLINICAL TRIALS*Further company coverage: 2659.HK* ((Reuters.Briefs@th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD8BSg84:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166966432","title":"BAO PHARMA-B Surges Over 10% In Session Following Clinical Trial Approval for Recombinant Ulinastatin","url":"https://stock-news.laohu8.com/highlight/detail?id=1166966432","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166966432?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:02","pubTimestamp":1783044169,"startTime":"0","endTime":"0","summary":"Shares of BAO PHARMA-B (02659) climbed more than 10% during the trading session. At the time of writing, the stock is up 4.82%, trading at HK$18.92 with a turnover of HK$8.4168 million. The company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119988416","title":"Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119988416","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119988416?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:04","pubTimestamp":1782817473,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange. The shares were repurchased at prices between...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153676444","title":"BAO PHARMA-B (02659) Repurchases 95,200 Shares for Approximately HK$1.686 Million on June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1153676444","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153676444?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:54","pubTimestamp":1782816873,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on June 30, 2026, the company repurchased 95,200 of its own shares at a total cost of approximately HK$1.686 million.The share buyback was executed at prices ranging from HK$17.38 to HK$17.81 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537020","title":"Shanghai Bao Pharma Files HKEX Next-day Disclosure on Share Buyback at HKD 17.38-17.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537020","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647537020?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:50","pubTimestamp":1782816637,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharma files HKEX next-day disclosure on share buyback at HKD 17.38-17.81Shanghai Bao Pharmaceuticals repurchased 95,200 H shares on June 30, 2026 for treasury, with no shares cancelled.B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4hrxhR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647728585","title":"Shanghai Bao Pharmaceuticals Says NMPA Approves IND Application for BJ044 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2647728585","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647728585?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:40","pubTimestamp":1782783652,"startTime":"0","endTime":"0","summary":"June 30 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd <2659.HK>::*NMPA APPROVES IND APPLICATION FOR BJ044 INJECTION, PERMITTING CLINICAL TRIALS*Further company coverage: 2659.HK* ((Reuters.Briefs@th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nRSD8BSg84:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173979252","title":"Yidu Tech Achieves Historic Annual Profit Turnaround; Key HKEX Announcements on M&A, Clinical Trials, and AI Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=1173979252","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173979252?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:10","pubTimestamp":1782781850,"startTime":"0","endTime":"0","summary":"Key corporate developments have been announced across the Hong Kong market. Bao Pharma-B (HKEX: 02659) reported that the clinical trial application for its BJ044 injection (recombinant ulinastatin)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1149","BK1617","BK1214","BK1161","BK1518","BK4588","00638","BK1189","VXUS","BK1144","01783","02659","02431","BK1148","02158","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":131,"code":"91000000","status":"200"}]}}